Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

11/10/2019 07:00

Oct 11 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2019        Aug 31, 2018     May 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            164.50              153.53           658.50    
                 (+7.1 pct)          (+10.7 pct)      (+7.7 pct)  
  Operating          7.02                7.00            24.80    
                 (+0.4 pct)          (+11.8 pct)      (+0.1 pct)  
  Recurring          7.53                7.55            27.30    
                 (-0.3 pct)          (+10.2 pct)      (+0.0 pct)  
  Net                5.05                4.89            19.19    
                 (+3.4 pct)          (+5.3 pct)       (+0.0 pct)  
  EPS            255.05 yen          246.73 yen       969.21 yen  
  Ann Div                            100.00 yen       100.00 yen  
  -Q2 div                             45.00 yen        50.00 yen  
  -Q4 div                             55.00 yen        50.00 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T